{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-084687","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2026-08-03T20:47:55+00:00","discovered_at":"2026-08-03T20:49:02.339141+00:00","generated_at":"2026-08-03T20:49:09.171259+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Jasper Therapeutics 2026 annual meeting voting results; all proposals approved","bullets":["Elected Judith Shizuru and Tom Wiggans as Class II directors with ~9.27M and ~9.28M votes for, respectively.","Ratified PricewaterhouseCoopers as independent auditor for FY2026 with 20.6M votes for (97.7% of votes cast).","Advisory say-on-pay approved with 9.0M for, 604k against, 73k abstain (excluding 11.4M broker non-votes).","Quorum of 75% (21.1M of 28.0M shares) represented at the July 31, 2026 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-084687","json":"https://secwatch.observer/filing/0001213900-26-084687.json","markdown":"https://secwatch.observer/filing/0001213900-26-084687.md","text":"https://secwatch.observer/filing/0001213900-26-084687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/0001213900-26-084687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026084687/ea0300286-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:49:09.171259+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}